Tafero EM(Тенофовир алафенамид и эмтрицитабин)

Tafero-EM is a recently launched drug for treating HIV and hepatitis B. The Tafero-EM tablet contains the active ingredients Emtricitabine (Emtricitabine) 200 mg and Tenofovir Alafenamide (Tenofovir Alafenamide) 25 mg, which helps stop the growth of the HBV virus and hiv in the blood.

This drug is new and necessary for the treatment of HIV (human immunodeficiency virus). Tafero-EM differs from its competitors in the absence of negative side effects. The main components that make up its composition are alafanamide at a dose of 25 milligrams, embricitabine at a dose of 200 milligrams. They determine the effect of the use of the drug.

Tafero-EM is a drug that is taken during antiretroviral therapy in patients with stage 1 HIV. An important distinguishing feature of the drug is a high level of effectiveness and a minimum of side effects.